2014

1. Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: Final analysis of a multicentre, open-label, early-access protocol trial

   The Lancet Oncology, Vol. 15, Núm. 11, pp. 1263-1268